Threshold Group’s Novo Nordisk NVO Stock Holding History

Threshold Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$241K	Hold	10,000	–	–	0.19%	43
2017 Q2	$214K	Buy	+10,000	New	+$202K	0.19%	40

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Threshold Group's NVO Position: Q3 2017 in Review

Threshold Group held its Novo Nordisk (NVO) position steady in Q3 2017 at 10,000 shares worth $241K. The position accounts for 0.19% of the portfolio, ranked #43.

Threshold Group first reported a position in NVO in Q2 2017 and has held it in 2 quarters since. 491 funds tracked by Wall St. Rank hold NVO as of Q3 2017.

Threshold Group held 10,000 shares of Novo Nordisk worth $241K as of Q3 2017.
Threshold Group left its Novo Nordisk share count unchanged in Q3 2017.
Novo Nordisk made up 0.19% of Threshold Group's portfolio in Q3 2017, its #43 holding.
Threshold Group first reported a position in Novo Nordisk in Q2 2017 and has held it in 2 quarters since.
491 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2017.

Based on Threshold Group's 13F filing for Q3 2017, filed 14 Nov 2017.